Once proven safe and effective, the herbal capsule will be the first definitive treatment for dengue. CONTRIBUTED PHOTO
The Tuklas Lunas program of the Department of Science and Technology (DoST) remains in full swing as one of its projects is set for completion soon.
The clinical trial, which costs nearly P12 million and is being implemented by Pharmalytics Corp., is funded by the DoST through the Philippine Council for Health Research and Development (PCHRD).